Senior insider sale
Chief Legal Officer at DEFINIUM THERAPEUTICS, INC. — senior position signals high conviction
$155.5K
22.28K shares
What this filing means
SULLIVAN MARK plans to sell 22.28K shares of DEFINIUM THERAPEUTICS, INC. valued at approximately $155.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/25/2024ACC: 0001104659-24-102910
Officer· Chief Legal Officer
Since Feb 2026
22.28K
Shares to sell
$155.5K
Approx. market value
4.43K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
9/25/2024
4.43KTotal acquired4.43K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/25/2024 | Restricted Stock Vesting Compensation | 4.43K | — |
| Total | 4.43K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
17.85K
Market value
$129.0K
6/25/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
4.43K
Market value
$26.5K
9/25/2024
Total
Units
22.28K
Value
$155.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/25/2024 | 17.85K | $129.0K | — | Completed |
| Planned — Approximate Date | ||||
9/25/2024 | 4.43K | $26.5K | NASDAQ | Planned |
| Total | 22.28K | $155.5K | ||